Date published: 2025-9-10

021-6093-6350

SCBT Portrait Logo
Seach Input

eIF3M 抑制因子

eIF3M inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the eukaryotic translation initiation factor 3 subunit M (eIF3M). eIF3M is a component of the eIF3 complex, which is a crucial player in the initiation phase of eukaryotic translation. The eIF3 complex is the largest and most complex of the translation initiation factors, composed of multiple subunits, including eIF3M. This complex plays a critical role in the recruitment of the small ribosomal subunit to the mRNA, the scanning of the mRNA for the start codon, and the assembly of the translation machinery. Inhibiting eIF3M can disrupt the overall function of the eIF3 complex, thereby impeding the translation initiation process. This makes eIF3M inhibitors important tools in research for studying the specific role of this subunit in translation and its broader impact on protein synthesis.

The study of eIF3M inhibitors provides valuable insights into the mechanistic aspects of translation initiation. By selectively inhibiting eIF3M, researchers can dissect the specific contributions of this subunit to the eIF3 complex's function and its interaction with other components of the translation machinery. This approach allows scientists to explore how eIF3M influences the regulation of gene expression at the translational level, as well as its involvement in various cellular processes that depend on efficient protein synthesis. Furthermore, eIF3M inhibitors can help identify potential regulatory networks that modulate the activity of the eIF3 complex, offering a deeper understanding of how cells control protein production under different physiological conditions. Overall, eIF3M inhibitors are essential tools for advancing our knowledge of translation initiation and the complex molecular mechanisms that govern this fundamental process in eukaryotic cells.

関連項目

Items 1 to 10 of 14 total

展示:

产品名称CAS #产品编号数量价格应用排名

Salubrinal

405060-95-9sc-202332
sc-202332A
1 mg
5 mg
$33.00
$102.00
87
(2)

Salubrinal抑制eIF2α去磷酸化,延长磷酸化时间,从而减少翻译起始。

Guanabenz HCl

23113-43-1sc-507500
100 mg
$241.00
(0)

Guanabenz通过激活eIF2α磷酸酶PP1来减少eIF2α的磷酸化,使翻译得以正常进行。

GSK 2606414

1337531-36-8sc-490182
sc-490182A
5 mg
25 mg
$160.00
$561.00
(0)

GSK2606414抑制PERK的活性,后者是一种磷酸化eIF2α的激酶,可降低eIF2α的磷酸化水平。

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

顺铂通过造成DNA损伤、触发综合应激反应和eIF2α磷酸化,间接影响eIF2α。

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin诱导ER应激,激活PERK并导致eIF2α磷酸化,从而抑制蛋白质合成。

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

依托泊苷会导致DNA损伤,从而引发细胞应激反应,可能从RNAi途径转移细胞资源,从而下调eIF2C2。

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

硼替佐米抑制蛋白酶体,影响蛋白质的更新。这可能会破坏细胞蛋白质的平衡,从而降低eIF2C2的稳定性或合成。

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

放线菌素D通过插入DNA来阻碍RNA合成。这会导致RNA衍生过程的整体下调,其中可能包括eIF2C2水平的降低。

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

环己酰胺通过抑制蛋白质合成,可能会阻止新的eIF2C2分子的产生,从而导致eIF2C2的净减少,因为现有蛋白质会降解。

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

阿霉素(Doxorubicin)对DNA的损害可能会导致细胞优先修复DNA,而忽略常规功能,从而抑制RNAi机制并降低eIF2C2水平。